Display options
Share it on

Stem Cells Int. 2016;2016:6810562. doi: 10.1155/2016/6810562. Epub 2016 May 04.

Biomaterial Applications in Cell-Based Therapy in Experimental Stroke.

Stem cells international

Ligia S B Boisserand, Tomonobu Kodama, Jérémie Papassin, Rachel Auzely, Anaïck Moisan, Claire Rome, Olivier Detante

Affiliations

  1. Inserm, U1216, BP 170, 38042 Grenoble Cedex 9, France; Grenoble Institut des Neurosciences (GIN), Université Grenoble Alpes, 38000 Grenoble, France; CAPES Foundation, Ministry of Education of Brazil, 70040-020 Brasília, DF, Brazil.
  2. Institute for Frontier Medical Sciences, Department of Reparative Materials, Kyoto University, Kyoto 606-8507, Japan.
  3. Inserm, U1216, BP 170, 38042 Grenoble Cedex 9, France; Grenoble Institut des Neurosciences (GIN), Université Grenoble Alpes, 38000 Grenoble, France; CHU Grenoble Alpes, Stroke Unit, Department of Neurology, CS 10217, 38043 Grenoble, France.
  4. CERMAV, CNRS, CERMAV, Université Grenoble Alpes, 38000 Grenoble, France.
  5. Cell Therapy and Engineering Unit, EFS Rhône Alpes, 464 route de Lancey, 38330 Saint-Ismier, France.
  6. Inserm, U1216, BP 170, 38042 Grenoble Cedex 9, France; Grenoble Institut des Neurosciences (GIN), Université Grenoble Alpes, 38000 Grenoble, France.
  7. Inserm, U1216, BP 170, 38042 Grenoble Cedex 9, France; Grenoble Institut des Neurosciences (GIN), Université Grenoble Alpes, 38000 Grenoble, France; Institute for Frontier Medical Sciences, Department of Reparative Materials, Kyoto University, Kyoto 606-8507, Japan; CHU Grenoble Alpes, Stroke Unit, Department of Neurology, CS 10217, 38043 Grenoble, France.

PMID: 27274738 PMCID: PMC4870368 DOI: 10.1155/2016/6810562

Abstract

Stroke is an important health issue corresponding to the second cause of mortality and first cause of severe disability with no effective treatments after the first hours of onset. Regenerative approaches such as cell therapy provide an increase in endogenous brain structural plasticity but they are not enough to promote a complete recovery. Tissue engineering has recently aroused a major interesting development of biomaterials for use into the central nervous system. Many biomaterials have been engineered based on natural compounds, synthetic compounds, or a mix of both with the aim of providing polymers with specific properties. The mechanical properties of biomaterials can be exquisitely regulated forming polymers with different stiffness, modifiable physical state that polymerizes in situ, or small particles encapsulating cells or growth factors. The choice of biomaterial compounds should be adapted for the different applications, structure target, and delay of administration. Biocompatibilities with embedded cells and with the host tissue and biodegradation rate must be considerate. In this paper, we review the different applications of biomaterials combined with cell therapy in ischemic stroke and we explore specific features such as choice of biomaterial compounds and physical and mechanical properties concerning the recent studies in experimental stroke.

References

  1. Stroke. 2001 Apr;32(4):1005-11 - PubMed
  2. Cell Transplant. 2002;11(3):275-81 - PubMed
  3. Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):17089-94 - PubMed
  4. Restor Neurol Neurosci. 1998;13(3-4):193-203 - PubMed
  5. Biomaterials. 2003 Aug;24(19):3311-31 - PubMed
  6. Brain Res. 2004 Jun 4;1010(1-2):108-16 - PubMed
  7. Proc Natl Acad Sci U S A. 2004 Aug 10;101(32):11839-44 - PubMed
  8. J Clin Invest. 2004 Aug;114(3):330-8 - PubMed
  9. J Neurosci Res. 2004 Oct 15;78(2):215-23 - PubMed
  10. Glia. 2005 Feb;49(3):407-17 - PubMed
  11. J Neurol Sci. 2005 Jun 15;233(1-2):121-3 - PubMed
  12. Stroke. 2005 Sep;36(9):e100-43 - PubMed
  13. Neuroscience. 2005;136(1):123-34 - PubMed
  14. Stem Cells Dev. 2005 Oct;14(5):595-604 - PubMed
  15. Brain Res. 2005 Dec 14;1065(1-2):8-19 - PubMed
  16. Exp Neurol. 2006 Apr;198(2):313-25 - PubMed
  17. J Cereb Blood Flow Metab. 2007 Jan;27(1):6-13 - PubMed
  18. Ann Neurol. 2006 May;59(5):735-42 - PubMed
  19. Nat Rev Neurosci. 2006 May;7(5):395-406 - PubMed
  20. J Agric Food Chem. 2006 Sep 6;54(18):6629-33 - PubMed
  21. J Biomed Mater Res A. 2006 Dec 15;79(4):902-12 - PubMed
  22. Int J Biol Macromol. 2007 Mar 10;40(4):374-80 - PubMed
  23. Stroke. 2007 Feb;38(2 Suppl):817-26 - PubMed
  24. Stroke. 2007 Jul;38(7):2150-6 - PubMed
  25. J Neurol Sci. 2008 Feb 15;265(1-2):102-4 - PubMed
  26. Tissue Eng. 2007 Oct;13(10):2515-23 - PubMed
  27. Brain. 2008 Mar;131(Pt 3):616-29 - PubMed
  28. J Biomed Mater Res B Appl Biomater. 2008 Oct;87(1):251-63 - PubMed
  29. Semin Immunol. 2008 Apr;20(2):86-100 - PubMed
  30. J Cell Sci. 2008 Feb 1;121(Pt 3):255-64 - PubMed
  31. J Cereb Blood Flow Metab. 2008 Sep;28(9):1530-42 - PubMed
  32. Proc Natl Acad Sci U S A. 2008 Sep 23;105(38):14638-43 - PubMed
  33. Stroke. 2009 Mar;40(3 Suppl):S143-5 - PubMed
  34. Eur J Pharm Sci. 2009 Apr 11;37(1):43-52 - PubMed
  35. J Cereb Blood Flow Metab. 2009 Apr;29(4):780-91 - PubMed
  36. Biomaterials. 2009 Jun;30(16):2985-94 - PubMed
  37. Biomaterials. 2009 Aug;30(22):3711-22 - PubMed
  38. Chem Soc Rev. 2009 Apr;38(4):1139-51 - PubMed
  39. Cell Transplant. 2009;18(7):815-26 - PubMed
  40. Biomaterials. 2009 Sep;30(27):4695-9 - PubMed
  41. J Cereb Blood Flow Metab. 2010 Mar;30(3):534-44 - PubMed
  42. Cell Transplant. 2009;18(12):1369-79 - PubMed
  43. Surg Neurol. 2009 Dec;72 Suppl 2:S50-4 - PubMed
  44. Biomaterials. 2010 Mar;31(8):2105-20 - PubMed
  45. Biomaterials. 2010 Mar;31(8):2184-92 - PubMed
  46. Anat Rec (Hoboken). 2010 May;293(5):911-7 - PubMed
  47. Macromol Biosci. 2010 Jun 11;10(6):563-79 - PubMed
  48. Cell Transplant. 2010;19(9):1063-71 - PubMed
  49. J Neurosci Nurs. 2010 Apr;42(2):80-7 - PubMed
  50. Neurorehabil Neural Repair. 2010 Sep;24(7):636-44 - PubMed
  51. J Neurosci. 2010 Apr 28;30(17):5843-54 - PubMed
  52. Glia. 2010 Jul;58(9):1074-81 - PubMed
  53. Neurosurgery. 2010 Jun;66(6):1140-7; discussion 1147 - PubMed
  54. J Cardiovasc Transl Res. 2010 Aug;3(4):410-6 - PubMed
  55. Exp Transl Stroke Med. 2010 Jul 19;2(1):13 - PubMed
  56. J Biomed Mater Res A. 2010 Sep 15;94(4):1162-71 - PubMed
  57. PLoS One. 2010 Sep 22;5(9):e12779 - PubMed
  58. Biomaterials. 2011 Jan;32(3):899-908 - PubMed
  59. J Neurosci Res. 2011 Feb;89(2):127-41 - PubMed
  60. Neurobiol Dis. 2011 Mar;41(3):717-24 - PubMed
  61. J Control Release. 2011 Oct 30;155(2):193-9 - PubMed
  62. Pharm Res. 2011 Jun;28(6):1406-14 - PubMed
  63. Biomaterials. 2011 Aug;32(24):5688-97 - PubMed
  64. Eur J Neurosci. 2011 Jun;33(12):2187-202 - PubMed
  65. Stem Cells. 2011 Feb;29(2):274-85 - PubMed
  66. Dev Neurobiol. 2011 Nov;71(11):1018-39 - PubMed
  67. Immunol Rev. 2011 Sep;243(1):191-205 - PubMed
  68. Neurosci Res. 2012 Mar;72(3):199-213 - PubMed
  69. Biomaterials. 2012 Apr;33(10):2858-71 - PubMed
  70. J Pharm Pharmacol. 2012 Mar;64(3):353-9 - PubMed
  71. Nanotechnology. 2012 Mar 9;23(9):095705 - PubMed
  72. Biomed Mater. 2012 Apr;7(2):024101 - PubMed
  73. Stroke. 2012 Jun;43(6):1624-31 - PubMed
  74. NMR Biomed. 2012 Dec;25(12):1340-8 - PubMed
  75. Biomaterials. 2012 Oct;33(30):7435-46 - PubMed
  76. PLoS One. 2012;7(7):e41340 - PubMed
  77. Stem Cells Int. 2012;2012:915160 - PubMed
  78. J Nucl Med. 2013 Jan;54(1):145-50 - PubMed
  79. Rev Neurol (Paris). 2013 Apr;169(4):291-306 - PubMed
  80. J Control Release. 2013 Mar 28;166(3):197-202 - PubMed
  81. Acta Biomater. 2013 Jun;9(6):6834-43 - PubMed
  82. Biomatter. 2013 Jan-Mar;3(1):null - PubMed
  83. Biomaterials. 2013 Jul;34(22):5521-9 - PubMed
  84. Biomaterials. 2013 Aug;34(24):5937-46 - PubMed
  85. J Control Release. 2013 Nov 28;172(1):1-11 - PubMed
  86. Nat Rev Immunol. 2013 Oct;13(10):755-63 - PubMed
  87. PLoS One. 2013 Sep 04;8(9):e73244 - PubMed
  88. Stroke. 2013 Dec;44(12):3473-81 - PubMed
  89. Brain Sci. 2013 Jul 3;3(1):239-61 - PubMed
  90. Brain. 2013 Dec;136(Pt 12):3561-77 - PubMed
  91. Front Neurosci. 2013 Oct 24;7:194 - PubMed
  92. Glia. 2014 Jan;62(1):1-16 - PubMed
  93. J Biomed Mater Res A. 2014 May;102(5):1222-30 - PubMed
  94. Int J Mol Sci. 2014 Feb 28;15(3):3640-59 - PubMed
  95. Acta Biomater. 2014 Jul;10(7):3126-35 - PubMed
  96. J Biomater Appl. 2014 Sep;29(3):442-53 - PubMed
  97. J Cereb Blood Flow Metab. 2014 Aug;34(8):1354-62 - PubMed
  98. J Tissue Eng Regen Med. 2017 Feb;11(2):375-381 - PubMed
  99. PLoS One. 2014 Aug 15;9(8):e104741 - PubMed
  100. Pathol Biol (Paris). 2015 Feb;63(1):32-4 - PubMed
  101. PLoS One. 2014 Sep 08;9(9):e105129 - PubMed
  102. Nat Rev Mol Cell Biol. 2014 Dec;15(12):786-801 - PubMed
  103. Cerebrovasc Dis. 2014;38(5):344-53 - PubMed
  104. Rev Neurol (Paris). 2014 Dec;170(12):779-98 - PubMed
  105. Biomaterials. 2015 Apr;47:1-12 - PubMed
  106. Cell Biochem Funct. 2015 Jun;33(4):174-82 - PubMed
  107. Biomaterials. 2015 Aug;61:115-25 - PubMed
  108. Front Bioeng Biotechnol. 2015 May 15;3:67 - PubMed
  109. Mol Cell Ther. 2014 Jul 01;2:19 - PubMed
  110. Biomaterials. 2015 Sep;63:158-67 - PubMed
  111. Mol Neurobiol. 2016 Aug;53(6):3842-3853 - PubMed
  112. Sci Rep. 2015 Jul 24;5:11743 - PubMed
  113. Adv Funct Mater. 2014 Nov 26;24(44):7053-7062 - PubMed
  114. Acta Biomater. 2015 Nov;27:116-130 - PubMed
  115. Tissue Eng Part A. 2015 Nov;21(21-22):2744-56 - PubMed
  116. Expert Opin Biol Ther. 2016;16(1):43-56 - PubMed
  117. Carbohydr Polym. 2016 Jan 1;135:308-15 - PubMed
  118. Neural Regen Res. 2015 Aug;10(8):1265-70 - PubMed
  119. Carbohydr Polym. 2016 Jan 20;136:764-71 - PubMed
  120. Acta Biomater. 2016 Jan;30:188-198 - PubMed
  121. Curr Opin Solid State Mater Sci. 2014 Dec;18(6):308-318 - PubMed

Publication Types